UNSPSC 51401553: Temazepam

This classification denotes an anti-anxiety agent, gaba modulator, hypnotic, and sedative with the molecular formula C16H13ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHB1QD2QSS, chemically known as 1,3-dihydro-7-chloro-3-hydroxy-1-methyl-5-phenyl-2h-1,4-benzodiazepin-2-one but generally known as temazepam, which bears US NIH Compound Identifier 5391. European Medicines Agency schedules Temazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10880MIG.

UNSPSC 51401553 Temazepam, a Commodity code, nominally covers a specific benzodiazepine pharmaceutical product; however, the recent state and local procurement activity tagged to this code does not reflect temazepam procurement. Seminole County, Florida posted an IFB on June 30, 2026, seeking to procure naloxone and drug deactivation systems — products unrelated to the code's stated scope. The mismatch between the code designation and the actual goods being solicited suggests either a data-entry error in the county's tagging system or a fundamental misalignment between the UNSPSC category and how the opportunity was classified at submission. This code shows little relevant recent activity aligned with its nominal pharmaceutical scope, and the single recent opportunity reflects a different commodity category entirely.

Without additional opportunities tagged to this Commodity code, no pattern of issuing-body mix, geographic concentration, or representative recent activity specific to temazepam procurement can be established from state and local sources. The Seminole County naloxone opportunity, while recent, does not inform procurement patterns for the code as described.